Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD



Rating:

Share or cite this content

Citations should be made in the following way:
N. Lane (Newcastle Upon Tyne, United Kingdom), S. Gillespie (Newcastle Upon Tyne, United Kingdom), T. Hartley (Newcastle Upon Tyne, United Kingdom), C. Echevarria (Newcastle Upon Tyne, United Kingdom), J. Steer (Newcastle Upon Tyne, United Kingdom), S. Bourke (Newcastle Upon Tyne, United Kingdom). Clinical prognostic tools and their use in COPD.. 542

Member's Comments

No comment yet.

Related content which might interest you: Clinical phenotyping of COPD patients: a simple tool with prognosis value Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 Simple functional performance tests as predictors of clinical outcomes in COPD Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases Year: 2015 Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014 Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index. Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019 COPD: algorithms and clinical management Source: Eur Respir J, 50 (5) 1701733; 10.1183/13993003.01733-2017 Year: 2017 The clinical and prognostic evaluation of patients with PAH Source: Annual Congress 2012 - Exercise testing in pulmonary arterial hypertension patients Year: 2012 Clinical clustering of COPD patients is useful to predict future COPD exacerbations Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Clinical and functional staging of COPD Source: Annual Congress 2004 - Diagnosis and staging of COPD Year: 2004 Clinical assessment and staging of COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014 COPD: implementing biomarkers to improve prognosis Source: Virtual Congress 2021 – Clinical year in review Year: 2021 The new prognostic multidimensional index HODEH in patient with COPD Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Clinical characteristics and prognostic features in infectious and non-infectious COPD exacerbations Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Clinical utility of impulse oscillation system (IOS) for the assessment of clinical status and therapeutic efficacy in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 421s Year: 2006 Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Clinical prediction guides in COPD, a real life evaluation Source: International Congress 2019 – Clinical implications of COPD management Year: 2019